CASSIOPEA | BUY, CHF95.6 | Coverage initiated
Cassiopea is a company focused on developing and commercialising safe and effective topical products with new mechanisms of action for a number of common dermatological conditions such as acne, androgenetic alopecia (AGA) and genital warts. The markets for acne and AGA have been starved of innovative products for decades and we believe the strong activity and safety of the company’s leading products will see them being well adopted by both physicians and patients alike.
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.